Norihiro Watanabe - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Norihiro Watanabe

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Leukemia Research|April 29, 2014

Screening of a heptamer-type sgRNA library for potential therapeutic agents against hematological malignanciesMasayuki Takahashi, Reyad A Elbarbary, Norihiro Watanabe, et al.

Journal for Immunotherapy of Cancer|September 17, 2020

Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.

Nature Biotechnology|July 15, 2020

Engineered off-the-shelf therapeutic T cells resist host immune rejectionFeiyan Mo, Norihiro Watanabe, Mary K McKenna, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2022

Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignanciesNorihiro Watanabe, Feiyan Mo, Rong Zheng, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2026

IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activityGabriel A Barragán Bravo, David A de la Cerda, Elisa Landoni, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Leukemia Research|April 29, 2014

Screening of a heptamer-type sgRNA library for potential therapeutic agents against hematological malignanciesMasayuki Takahashi, Reyad A Elbarbary, Norihiro Watanabe, et al.

Journal for Immunotherapy of Cancer|September 17, 2020

Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.

Nature Biotechnology|July 15, 2020

Engineered off-the-shelf therapeutic T cells resist host immune rejectionFeiyan Mo, Norihiro Watanabe, Mary K McKenna, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2022

Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignanciesNorihiro Watanabe, Feiyan Mo, Rong Zheng, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2026

IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activityGabriel A Barragán Bravo, David A de la Cerda, Elisa Landoni, et al.

Pageof 5